West Pharmaceutical Services, Inc. (WST) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 89.9M | 251.1M | 197.2M | 177.1M | 129.4M | 190.1M | 180.1M | 165M | 118.2M | 239.1M | 230.1M | 169.2M |
| Operating CF Margin % | 10.64% | 31.19% | 24.52% | 23.11% | 18.53% | 25.4% | 24.11% | 23.5% | 17% | 32.66% | 30.78% | 22.43% |
| Operating CF Growth % | -30.53% | 32.09% | 9.49% | 7.33% | 9.48% | -20.49% | -21.73% | -2.48% | -14.41% | 3.6% | 36.23% | -2.25% |
| Net Income | 138.8M | 132.1M | 140M | 131.8M | 89.8M | 130.1M | 136M | 111.3M | 115.3M | 137M | 161.3M | 155.1M |
| Depreciation & Amortization | 44.6M | 47M | 43M | 40.8M | 39.1M | 40.7M | 40.2M | 38.9M | 35.6M | 35.9M | 35.7M | 34.1M |
| Stock-Based Compensation | 6.6M | 6.7M | 8.4M | 7.4M | 1.3M | 4.3M | 5.1M | 4.3M | 5M | 1.4M | 5.9M | 7.5M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23.4M | -192M | 3.7M |
| Other Non-Cash Items | -100.1M | 1.5M | 3.7M | -2.8M | -900K | -8.5M | -1.1M | -3.6M | -3.1M | 14.5M | 194.4M | -5.9M |
| Working Capital Changes | 0 | 63.8M | 2.1M | -100K | 100K | 23.5M | -100K | 14.1M | -34.6M | 26.9M | 24.8M | -25.3M |
| Change in Receivables | 0 | 6.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4M | 0 | 0 |
| Change in Inventory | 0 | -62.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -13.5M | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.5M | 0 | 0 |
| Cash from Investing | -42.7M | -76.1M | -63.3M | -75.2M | -71.3M | -104.8M | -82.1M | -101.2M | -90.6M | -108.8M | -95.7M | -82.1M |
| Capital Expenditures | -42.7M | -76.1M | -63.3M | -75.2M | -71.3M | -104.9M | -81.3M | -100.2M | -90.6M | -108.7M | -95.8M | -75.4M |
| CapEx % of Revenue | 5.05% | 9.45% | 7.87% | 9.81% | 10.21% | 14.01% | 10.88% | 14.27% | 13.03% | 14.85% | 12.82% | 10% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 100K | -800K | -1M | 0 | -100K | 100K | -6.7M |
| Cash from Financing | -308.7M | -11.7M | -11.5M | -14.9M | -147M | -68.9M | -64.4M | -218.3M | -271M | -189.5M | -22.3M | -176.8M |
| Debt Issued (Net) | 0 | -300K | -300K | -300K | -200K | -100K | -3.5M | -23.4M | -600K | -600K | -600K | -500K |
| Equity Issued (Net) | 0 | -200K | 3.9M | -500K | -136M | -54.6M | -52.4M | -187.2M | -272.4M | -177.1M | -28.1M | -174.4M |
| Dividends Paid | -15.8M | -15.8M | -15.1M | -15.1M | -15.2M | -15.3M | -14.5M | -14.6M | -14.7M | -14.8M | -14M | -14.1M |
| Share Repurchases | 0 | -200K | -100K | -500K | -136M | -54.6M | -52.4M | -187.2M | -272.4M | -177.1M | -28.1M | -174.4M |
| Other Financing | -292.9M | 4.6M | 0 | 1M | 4.4M | 1.1M | 6M | 6.9M | 16.7M | 3M | 20.4M | 12.2M |
| Net Change in Cash | -269.9M | 162.8M | 118.8M | 105.5M | -80.4M | -6.3M | 44.7M | -155.6M | -252.1M | -44.7M | 102.3M | -90M |
| Free Cash Flow | 47.2M | 175M | 133.9M | 101.9M | 58.1M | 85.2M | 98.8M | 64.8M | 27.6M | 130.4M | 134.3M | 93.8M |
| FCF Margin % | 5.59% | 21.74% | 16.65% | 13.3% | 8.32% | 11.38% | 13.23% | 9.23% | 3.97% | 17.81% | 17.97% | 12.44% |
| FCF Growth % | -18.76% | 105.4% | 35.53% | 57.25% | 110.51% | -34.66% | -26.43% | -30.92% | -50.71% | -4.05% | 20.88% | -12.34% |
| FCF per Share | 0.65 | 2.41 | 1.84 | 1.40 | 0.80 | 1.16 | 1.35 | 0.88 | 0.37 | 1.74 | 1.78 | 1.24 |
| FCF Conversion (FCF/Net Income) | 0.65x | 1.90x | 1.41x | 1.34x | 1.44x | 1.46x | 1.32x | 1.48x | 1.03x | 1.75x | 1.43x | 1.09x |
| Interest Paid | 0 | 300K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |